Group A and Group C Meningococcal Conjugate Vaccine (Olymvax Biopharmaceuticals)

A群C群脑膜炎球菌多糖结合疫苗（成都欧林生物科技）

Report date: 2025/11/06 17:01:28

Base Information

Drug NameGroup A and Group C Meningococcal Conjugate Vaccine (Olymvax Biopharmaceuticals)

Drug Alias NameGroup A and Group C Meningococcal Conjugate Vaccine

ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I) +[5]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningitisMeningitis, Meningococcal

Global Approved IndicationsMeningitis

Approved Indications in ChinaMeningitis

Original Approved Country/TerritoryMainland China

Original Approved Date2020/09/30

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesChengdu Oulin Biological Science & Technology Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChengdu Oulin Biological Science & Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsMeningitis

Inactive IndicationsMeningitis, Meningococcal

Other Information

ATC CodeJ07AH